Parenteral Drugs (India) (BOM:524689) YoY EBITDA Growth : 1,256.89% (As of Mar. 2022)

View and export this data going back to 2001. Start your Free Trial

What is Parenteral Drugs (India) YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Parenteral Drugs (India)'s YoY EBITDA Growth for the quarter that ended in Mar. 2022 was 1,256.89%.

Parenteral Drugs (India)'s EBITDA per Share for the three months ended in Mar. 2022 was ₹15.55.

Parenteral Drugs (India) YoY EBITDA Growth Historical Data

The historical data trend for Parenteral Drugs (India)'s YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parenteral Drugs (India) YoY EBITDA Growth Chart

Parenteral Drugs (India) Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

YoY EBITDA Growth

Get a 7-Day Free Trial

92.81

-1,155.07

11.09

18.91

418.28

Parenteral Drugs (India) Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
YoY EBITDA Growth	Get a 7-Day Free Trial															187.95	54.89	49.49	-12.41	1,256.89

Parenteral Drugs (India) YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Parenteral Drugs (India)'s YoY EBITDA Growth for the fiscal year that ended in Mar. 2022 is calculated as:

	YoY EBITDA Growth (A: Mar. 2022 )
=	(EBITDA per Share (A: Mar. 2022 )	-	EBITDA per Share (A: Mar. 2021 ))	/	\| EBITDA per Share (A: Mar. 2021 ) \|
=	(12.499	-	-3.927)	/	\| -3.927 \|
=	418.28 %

Parenteral Drugs (India)'s YoY EBITDA Growth for the quarter that ended in Mar. 2022 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2022 )
=	(EBITDA per Share (Q: Mar. 2022 )	-	EBITDA per Share (Q: Mar. 2021 ))	/	\| EBITDA per Share (Q: Mar. 2021 )) \|
=	(15.55	-	1.146)	/	\| 1.146 \|
=	1,256.89 %

Parenteral Drugs (India) YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Parenteral Drugs (India)'s YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Parenteral Drugs (India) (BOM:524689) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parenteral Drugs (India) Ltd (BOM:524689) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

N/A

Address

Navlakha Crossing, A. B. Road, Shree Ganesh Chambers, Indore, MP, IND, 452001

Website

http://www.pdindia.com

Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) fluids, oncology, anesthesia, and export products. Its IV fluids products include carbohydrates and electrolytes, diuretics, dialysis, and irrigation solution, anti-infective and anti-fungal, and other pharmaceutical products.

Parenteral Drugs (India) (BOM:524689) Headlines

No Headlines